Adamas Pharmaceuticals, Inc. Debt to Equity Ratio 2014-2021 | ADMS
Current and historical debt to equity ratio values for Adamas Pharmaceuticals, Inc. (ADMS) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Adamas Pharmaceuticals, Inc. debt/equity for the three months ending September 30, 2021 was .
| Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2021-09-30 | $0.17B | $-0.02B | -7.66 |
| 2021-06-30 | $0.16B | $-0.00B | -38.35 |
| 2021-03-31 | $0.16B | $0.01B | 27.51 |
| 2020-12-31 | $0.17B | $-0.05B | -3.40 |
| 2020-09-30 | $0.17B | $-0.04B | -4.84 |
| 2020-06-30 | $0.16B | $-0.02B | -6.45 |
| 2020-03-31 | $0.16B | $-0.02B | -10.10 |
| 2019-12-31 | $0.16B | $-0.00B | -182.59 |
| 2019-09-30 | $0.16B | $0.02B | 8.13 |
| 2019-06-30 | $0.16B | $0.04B | 3.69 |
| 2019-03-31 | $0.16B | $0.06B | 2.49 |
| 2018-12-31 | $0.15B | $0.09B | 1.61 |
| 2018-09-30 | $0.14B | $0.11B | 1.25 |
| 2018-06-30 | $0.13B | $0.14B | 0.94 |
| 2018-03-31 | $0.13B | $0.17B | 0.76 |
| 2017-12-31 | $0.12B | $0.07B | 1.82 |
| 2017-09-30 | $0.05B | $0.09B | 0.60 |
| 2017-06-30 | $0.05B | $0.10B | 0.44 |
| 2017-03-31 | $0.01B | $0.12B | 0.07 |
| 2016-12-31 | $0.01B | $0.13B | 0.08 |
| 2016-09-30 | $0.01B | $0.14B | 0.09 |
| 2016-06-30 | $0.01B | $0.16B | 0.09 |
| 2016-03-31 | $0.01B | $0.17B | 0.07 |
| 2015-12-31 | $0.01B | $0.12B | 0.11 |
| 2015-09-30 | $0.01B | $0.12B | 0.10 |
| 2015-06-30 | $0.01B | $0.14B | 0.09 |
| 2015-03-31 | $0.01B | $0.14B | 0.07 |
| 2014-12-31 | $0.01B | $0.15B | 0.10 |
| 2014-09-30 | $0.01B | $0.13B | 0.05 |
| 2014-06-30 | $0.01B | $0.14B | 0.04 |
| 2014-03-31 | $0.01B | $0.07B | 0.11 |
| 2013-12-31 | $0.01B | $0.08B | 0.14 |
| 2013-09-30 | $0.00B | 0.00 | |
| 2013-06-30 | $0.00B | 0.00 | |
| 2013-03-31 | $0.00B | 0.00 | |
